Skip to main content

Peer Review reports

From: Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses

Original Submission
25 May 2018 Submitted Original manuscript
15 Aug 2018 Reviewed Reviewer Report - Reza Elaidi
22 Aug 2018 Reviewed Reviewer Report - Ian Davis
21 Sep 2018 Author responded Author comments - Irina Proskorovsky
Resubmission - Version 2
21 Sep 2018 Submitted Manuscript version 2
24 Sep 2018 Reviewed Reviewer Report - Ian Davis
2 Nov 2018 Reviewed Reviewer Report - Reza Elaidi
27 Nov 2018 Author responded Author comments - Irina Proskorovsky
Resubmission - Version 3
27 Nov 2018 Submitted Manuscript version 3
Publishing
29 Nov 2018 Editorially accepted
19 Dec 2018 Article published 10.1186/s12885-018-5157-0

You can find further information about peer review here.

Back to article page